{"id":"guideline-recommended-soc","safety":{"commonSideEffects":[{"rate":"1-5%","effect":"Pneumonitis"},{"rate":"5-10%","effect":"Hypothyroidism"},{"rate":"10-20%","effect":"Diarrhea"},{"rate":"20-30%","effect":"Fatigue"},{"rate":"30-40%","effect":"Nausea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By blocking the PD-1 receptor, the drug allows the immune system to recognize and attack cancer cells more effectively, leading to a reduction in tumor growth and spread. This mechanism is thought to be responsible for the drug's anti-tumor effects. The drug's ability to inhibit the PD-1 receptor also leads to a reduction in inflammation and an increase in the production of anti-tumor immune cells.","oneSentence":"This drug works by inhibiting the PD-1 receptor, which plays a key role in the immune system's ability to recognize and attack cancer cells.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:14:46.103Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Non-small cell lung cancer, PD-L1 positive"},{"name":"Head and neck squamous cell carcinoma"},{"name":"Melanoma"},{"name":"Kidney cancer"},{"name":"Class III-IV heart failure"}]},"trialDetails":[{"nctId":"NCT06859424","phase":"PHASE2","title":"A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation","status":"RECRUITING","sponsor":"Center for International Blood and Marrow Transplant Research","startDate":"2025-07-25","conditions":"AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category)","enrollment":358},{"nctId":"NCT05492955","phase":"NA","title":"Implementation of a Combination Intervention for Sustainable Blood Pressure Control","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2022-11-30","conditions":"Hypertension","enrollment":774},{"nctId":"NCT07226583","phase":"NA","title":"Using a Personalized Decision Support Tool to Help People With Type 1 Diabetes Manage Exercise","status":"NOT_YET_RECRUITING","sponsor":"Stanford University","startDate":"2026-04","conditions":"Type 1 Diabetes Mellitis, Type 1 Diabetes (T1D), Type 1 Diabetes Mellitus (T1DM)","enrollment":20},{"nctId":"NCT07418034","phase":"PHASE2","title":"A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)","status":"NOT_YET_RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2026-05","conditions":"Head and Neck Cancer, Head and Neck Squamous Cell Cancer, Head and Neck Squamous Cell Carcinoma","enrollment":132},{"nctId":"NCT06845774","phase":"NA","title":"The PROTECT (PrEP Optimization Through Telehealth Care and Treatment) Trial","status":"ENROLLING_BY_INVITATION","sponsor":"Hilary L Surratt, PhD","startDate":"2025-09-25","conditions":"HIV Prevention","enrollment":80},{"nctId":"NCT03904186","phase":"NA","title":"Effectiveness of an Integrated Treatment to Address Smoking Cessation and Anxiety/ Depression in People Living With HIV","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2019-12-19","conditions":"Human Immunodeficiency Virus, Smoking Cessation, Smoking, Cigarette","enrollment":131},{"nctId":"NCT05824767","phase":"PHASE4","title":"Serum Biomarkers to Predict Response to Angiotensin II in Septic Shock","status":"COMPLETED","sponsor":"University of New Mexico","startDate":"2023-04-17","conditions":"Septic Shock, Vasodilatory Shock","enrollment":40},{"nctId":"NCT07201519","phase":"PHASE2","title":"Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy","status":"RECRUITING","sponsor":"Michael J Cavnar, MD","startDate":"2026-01-23","conditions":"Colorectal Cancer Metastatic, Intrahepatic Cholangiocarcinoma","enrollment":80},{"nctId":"NCT07202247","phase":"PHASE2","title":"Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2026-01-23","conditions":"Prostate Carcinoma, Recurrent Prostate Carcinoma","enrollment":60},{"nctId":"NCT07002476","phase":"PHASE3","title":"Early Aggressive Strategy for Treatment of Lipid-Lowering in Acute Ischemic Stroke Delivered With Endovascular Therapy for Large Artery Occlusion","status":"RECRUITING","sponsor":"Shanghai East Hospital","startDate":"2025-06-19","conditions":"Stroke","enrollment":652},{"nctId":"NCT05646212","phase":"NA","title":"Integrating Treatment for Mental Disorders in Methadone Clinics in Ukraine","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ukrainian Institute on Public Health Policy","startDate":"2018-07-01","conditions":"Depression, Opioid Use Disorder","enrollment":1350},{"nctId":"NCT06124118","phase":"PHASE1","title":"Tumor Treating Fields for Locally Advanced NSCLC","status":"RECRUITING","sponsor":"University of Utah","startDate":"2024-04-04","conditions":"Non Small Cell Lung Cancer","enrollment":30},{"nctId":"NCT04951856","phase":"PHASE4","title":"Evolocumab or Normal Strategies to Reach LDL Objectives in Acute Myocardial Infarction Upbound to PCI","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2021-09-29","conditions":"STEMI - ST Elevation Myocardial Infarction, NSTEMI - Non-ST Segment Elevation MI","enrollment":2166},{"nctId":"NCT06842732","phase":"NA","title":"A Trial Testing a Two-way SMS Platform to Recognize and Prevent Wasting Among HIV-infected and HIV-exposed Uninfected Children in Kenya","status":"RECRUITING","sponsor":"University of Washington","startDate":"2025-06-05","conditions":"Malnutrition in Children, Children Exposed to HIV","enrollment":600},{"nctId":"NCT05503771","phase":"NA","title":"Improving Pediatrician Counseling About Infant Safe Sleep Using the Electronic Medical Record","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2022-09-30","conditions":"Sudden Infant Death, Sudden Unexplained Infant Death","enrollment":350},{"nctId":"NCT05841797","phase":"NA","title":"Evaluation of Problem Management Plus in Pregnant Women With HIV in Kenya","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2023-06-05","conditions":"Human Immunodeficiency Virus","enrollment":120},{"nctId":"NCT07178730","phase":"PHASE3","title":"NeoAdjuvant Therapy Comparing Sacituzumab Govitecan+Pembrolizumab vs. SoC Chemotherapy in Clinical Stage II-III, Triple-negative Early Breast Cancer","status":"NOT_YET_RECRUITING","sponsor":"West German Study Group","startDate":"2026-01-31","conditions":"Breast Cancer, Triple-negative Breast Cancer","enrollment":765},{"nctId":"NCT04694846","phase":"NA","title":"Effectiveness of an Enhanced Tobacco Intervention Protocol Compared to Standard Treatment in Helping Head and Neck and Lung Cancer Patients Starting Treatment to Reduce Cigarette Use","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2020-08-19","conditions":"Lung Non-Small Cell Carcinoma, Head and Neck Squamous Cell Carcinoma","enrollment":19},{"nctId":"NCT06369220","phase":"NA","title":"A Study of the Cobas® Liat CT/NG/MG Test Versus Current Standard Practice for Managing Participants at Increased Risk of Sexually Transmitted Infections","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2024-07-29","conditions":"Chlamydia Trachomatis Infection, Neisseria Gonorrhoeae Infection, Mycoplasma Genitalium Infection","enrollment":344},{"nctId":"NCT05081401","phase":"PHASE3","title":"Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)","status":"RECRUITING","sponsor":"Huashan Hospital","startDate":"2022-05-23","conditions":"Multidrug Resistant Tuberculosis, Rifampicin Resistant Tuberculosis, Pre-XDR-TB","enrollment":1050},{"nctId":"NCT05122793","phase":"NA","title":"\"HerzCheck\" - Detection of Early Heart Failure Using Telemedicine in Structurally Weak Regions","status":"ACTIVE_NOT_RECRUITING","sponsor":"German Heart Institute","startDate":"2021-06-21","conditions":"Heart Failure with Preserved Ejection Fraction","enrollment":4509},{"nctId":"NCT05341453","phase":"NA","title":"Hippotherapy in Children With Spinal Muscular Atrophy","status":"RECRUITING","sponsor":"Charles University, Czech Republic","startDate":"2022-04-22","conditions":"Spinal Muscular Atrophy","enrollment":16},{"nctId":"NCT05628779","phase":"NA","title":"Evaluating Edge-to-edge Transcatheter Tricuspid Valve Repair in Patients With Severe Symptomatic Tricuspid Regurgitation","status":"ENROLLING_BY_INVITATION","sponsor":"St. Antonius Hospital","startDate":"2022-12-12","conditions":"Tricuspid Valve Regurgitation, Nonrheumatic, Cardiac Catheterization, Heart Failure, Right Sided","enrollment":150},{"nctId":"NCT06262685","phase":"PHASE4","title":"Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins","status":"UNKNOWN","sponsor":"Instituto de Investigación Hospital Universitario La Paz","startDate":"2024-03-04","conditions":"Cardiovascular Diseases, Dyslipidemias, Statin Adverse Reaction","enrollment":216},{"nctId":"NCT03377127","phase":"NA","title":"Impact of Pharmacy Clinic on Diabetes Management","status":"COMPLETED","sponsor":"Corewell Health East","startDate":"2018-02-19","conditions":"Diabetes Mellitus, Type 2","enrollment":86},{"nctId":"NCT03106090","phase":"NA","title":"Studying Survivorship Care Plans in Head and Neck Cancer","status":"TERMINATED","sponsor":"Duke University","startDate":"2017-04-19","conditions":"Head and Neck Cancer","enrollment":6},{"nctId":"NCT03429699","phase":"NA","title":"Lifestyle Modification Intervention for Obese Children","status":"COMPLETED","sponsor":"Universiti Putra Malaysia","startDate":"2012-02-02","conditions":"Childhood Obesity, Life Style Modification","enrollment":50},{"nctId":"NCT01162421","phase":"PHASE4","title":"A Canadian Study to Evaluate Early Use of Adalimumab After Methotrexate Failure in Early Rheumatoid Arthritis","status":"COMPLETED","sponsor":"AbbVie (prior sponsor, Abbott)","startDate":"2010-09","conditions":"Rheumatoid Arthritis","enrollment":77}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":10,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"guideline-recommended SoC","genericName":"guideline-recommended SoC","companyName":"Shanghai East Hospital","companyId":"shanghai-east-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This drug works by inhibiting the PD-1 receptor, which plays a key role in the immune system's ability to recognize and attack cancer cells. Used for Non-small cell lung cancer, PD-L1 positive, Head and neck squamous cell carcinoma, Melanoma.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}